Loading…
Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals
Secretion of hydrolytic enzymes such as hemolysin is considered an important virulence attribute of the opportunistic pathogenic fungus Candida . It is known that Candida spp. isolated from HIV-infected patients produce copious hemolysins. As common antifungal agents may perturb the production of ex...
Saved in:
Published in: | Mycopathologia (1975) 2014-10, Vol.178 (3-4), p.207-215 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13 |
---|---|
cites | cdi_FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13 |
container_end_page | 215 |
container_issue | 3-4 |
container_start_page | 207 |
container_title | Mycopathologia (1975) |
container_volume | 178 |
creator | Anil, Sukumaran Hashem, Mohamed Vellappally, Sajith Patil, Shankargouda Bandara, H. M. H. N. Samaranayake, L. P. |
description | Secretion of hydrolytic enzymes such as hemolysin is considered an important virulence attribute of the opportunistic pathogenic fungus
Candida
. It is known that
Candida
spp. isolated from HIV-infected patients produce copious hemolysins. As common antifungal agents may perturb the production of extracellular enzymes, we evaluated the effect of three antifungals nystatin, amphotericin B and fluconazole on the hemolytic activity of
Candida albicans
and
Candida tropicalis
isolates from HIV-infected individuals. The impact of antimycotics on hemolytic activity was assessed by a previously described in vitro plate assay, after exposing ten isolates each of
C. albicans
and
C. tropicalis
recovered from HIV-infected individuals to sub-minimum inhibitory concentrations (sub-MIC) of nystatin, amphotericin B and fluconazole. All
Candida
isolates showed a significant reduction in hemolytic activity. The reduction was highest for amphotericin B-exposed
C. albicans
and
C. tropicalis
followed by nystatin and fluconazole. The effect of antimycotics was more pronounced on the hemolytic activity of
C. tropicalis
compared to that of
C. albicans
. Commonly used antifungal agents significantly suppress hemolysin activity of
Candida
species. This implies that the antifungals, in addition to their lethality, may modulate key virulence attributes of the yeast. The clinical relevance of this phenomenon in HIV disease and other similar pathologies remains to be determined. |
doi_str_mv | 10.1007/s11046-014-9802-0 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1566828742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A385802486</galeid><sourcerecordid>A385802486</sourcerecordid><originalsourceid>FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13</originalsourceid><addsrcrecordid>eNp1ks9u1DAQxiMEokvhAbggS1zgkGI7iZMcVytgI1WqxALiZjn-s7hK7GA7Ffs0fdVOtKWwCOTDyOPfN_aMvyx7SfAFwbh-FwnBJcsxKfO2wTTHj7IVqeoix01BH2crXGCSlw37dpY9i_EaY1CR-ml2RitS0pqyVXa7m_vcuu-2t8mHA9p4J7VLQSTrXUTeoLVL1sxuL4aIdvM0BR0j2urRD4doHVrLZG9sOizoVRAD2ginrBJIDL2VAmrA_iGZgp8gO9iIuugHkXREJvgRbbuveeeMlkkr1AF8Y9UMVz7PnhgI-sV9PM--fHj_ebPNL68-dpv1ZS6rmqVclH2j2qKsGK4NbllREtwqjHXFmr5XRkktelpRXPWKNAL6byBDjWx73QpDivPszbHuFPyPWcfERxulHgbhtJ8jJxVjDW3qkgL6-i_02s_BwesWCtcFKyn7TcHgNLfOeBiqXIryddFU8F3wMUBd_IOCpfRopXfaWMifCN6eCIBJ-mfaizlG3u0-nbLkyMrgYwza8CnYUYQDJ5gvBuJHA3EwEF8MxDFoXt03N_ejVg-KX44BgB6BCEdur8Mf3f-36h1ZxdCj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1560736426</pqid></control><display><type>article</type><title>Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals</title><source>Springer Nature</source><creator>Anil, Sukumaran ; Hashem, Mohamed ; Vellappally, Sajith ; Patil, Shankargouda ; Bandara, H. M. H. N. ; Samaranayake, L. P.</creator><creatorcontrib>Anil, Sukumaran ; Hashem, Mohamed ; Vellappally, Sajith ; Patil, Shankargouda ; Bandara, H. M. H. N. ; Samaranayake, L. P.</creatorcontrib><description>Secretion of hydrolytic enzymes such as hemolysin is considered an important virulence attribute of the opportunistic pathogenic fungus
Candida
. It is known that
Candida
spp. isolated from HIV-infected patients produce copious hemolysins. As common antifungal agents may perturb the production of extracellular enzymes, we evaluated the effect of three antifungals nystatin, amphotericin B and fluconazole on the hemolytic activity of
Candida albicans
and
Candida tropicalis
isolates from HIV-infected individuals. The impact of antimycotics on hemolytic activity was assessed by a previously described in vitro plate assay, after exposing ten isolates each of
C. albicans
and
C. tropicalis
recovered from HIV-infected individuals to sub-minimum inhibitory concentrations (sub-MIC) of nystatin, amphotericin B and fluconazole. All
Candida
isolates showed a significant reduction in hemolytic activity. The reduction was highest for amphotericin B-exposed
C. albicans
and
C. tropicalis
followed by nystatin and fluconazole. The effect of antimycotics was more pronounced on the hemolytic activity of
C. tropicalis
compared to that of
C. albicans
. Commonly used antifungal agents significantly suppress hemolysin activity of
Candida
species. This implies that the antifungals, in addition to their lethality, may modulate key virulence attributes of the yeast. The clinical relevance of this phenomenon in HIV disease and other similar pathologies remains to be determined.</description><identifier>ISSN: 0301-486X</identifier><identifier>EISSN: 1573-0832</identifier><identifier>DOI: 10.1007/s11046-014-9802-0</identifier><identifier>PMID: 25142726</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Amphotericin B ; Amphotericin B - pharmacology ; Antifungal agents ; Antifungal Agents - pharmacology ; Antiparasitic agents ; Biocides ; Biomedical and Life Sciences ; Candida albicans ; Candida albicans - drug effects ; Candida albicans - isolation & purification ; Candida albicans - metabolism ; Candida tropicalis ; Candida tropicalis - drug effects ; Candida tropicalis - isolation & purification ; Candida tropicalis - metabolism ; Candidiasis, Oral - microbiology ; Dentistry ; Enzymes ; Eukaryotic Microbiology ; Fluconazole ; Fluconazole - pharmacology ; Fungi ; Health aspects ; Hemolysin Proteins - antagonists & inhibitors ; Hemolysin Proteins - secretion ; HIV ; HIV (Viruses) ; HIV infection ; HIV Infections - complications ; HIV patients ; Human immunodeficiency virus ; Humans ; Infections ; Life Sciences ; Medical Microbiology ; Microbial Ecology ; Microbiological Techniques ; Microbiology ; Nystatin - pharmacology ; Plant Sciences ; Virulence ; Virulence (Microbiology) ; Virulence Factors - antagonists & inhibitors ; Virulence Factors - metabolism</subject><ispartof>Mycopathologia (1975), 2014-10, Vol.178 (3-4), p.207-215</ispartof><rights>Springer Science+Business Media Dordrecht 2014</rights><rights>COPYRIGHT 2014 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13</citedby><cites>FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25142726$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anil, Sukumaran</creatorcontrib><creatorcontrib>Hashem, Mohamed</creatorcontrib><creatorcontrib>Vellappally, Sajith</creatorcontrib><creatorcontrib>Patil, Shankargouda</creatorcontrib><creatorcontrib>Bandara, H. M. H. N.</creatorcontrib><creatorcontrib>Samaranayake, L. P.</creatorcontrib><title>Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals</title><title>Mycopathologia (1975)</title><addtitle>Mycopathologia</addtitle><addtitle>Mycopathologia</addtitle><description>Secretion of hydrolytic enzymes such as hemolysin is considered an important virulence attribute of the opportunistic pathogenic fungus
Candida
. It is known that
Candida
spp. isolated from HIV-infected patients produce copious hemolysins. As common antifungal agents may perturb the production of extracellular enzymes, we evaluated the effect of three antifungals nystatin, amphotericin B and fluconazole on the hemolytic activity of
Candida albicans
and
Candida tropicalis
isolates from HIV-infected individuals. The impact of antimycotics on hemolytic activity was assessed by a previously described in vitro plate assay, after exposing ten isolates each of
C. albicans
and
C. tropicalis
recovered from HIV-infected individuals to sub-minimum inhibitory concentrations (sub-MIC) of nystatin, amphotericin B and fluconazole. All
Candida
isolates showed a significant reduction in hemolytic activity. The reduction was highest for amphotericin B-exposed
C. albicans
and
C. tropicalis
followed by nystatin and fluconazole. The effect of antimycotics was more pronounced on the hemolytic activity of
C. tropicalis
compared to that of
C. albicans
. Commonly used antifungal agents significantly suppress hemolysin activity of
Candida
species. This implies that the antifungals, in addition to their lethality, may modulate key virulence attributes of the yeast. The clinical relevance of this phenomenon in HIV disease and other similar pathologies remains to be determined.</description><subject>Amphotericin B</subject><subject>Amphotericin B - pharmacology</subject><subject>Antifungal agents</subject><subject>Antifungal Agents - pharmacology</subject><subject>Antiparasitic agents</subject><subject>Biocides</subject><subject>Biomedical and Life Sciences</subject><subject>Candida albicans</subject><subject>Candida albicans - drug effects</subject><subject>Candida albicans - isolation & purification</subject><subject>Candida albicans - metabolism</subject><subject>Candida tropicalis</subject><subject>Candida tropicalis - drug effects</subject><subject>Candida tropicalis - isolation & purification</subject><subject>Candida tropicalis - metabolism</subject><subject>Candidiasis, Oral - microbiology</subject><subject>Dentistry</subject><subject>Enzymes</subject><subject>Eukaryotic Microbiology</subject><subject>Fluconazole</subject><subject>Fluconazole - pharmacology</subject><subject>Fungi</subject><subject>Health aspects</subject><subject>Hemolysin Proteins - antagonists & inhibitors</subject><subject>Hemolysin Proteins - secretion</subject><subject>HIV</subject><subject>HIV (Viruses)</subject><subject>HIV infection</subject><subject>HIV Infections - complications</subject><subject>HIV patients</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infections</subject><subject>Life Sciences</subject><subject>Medical Microbiology</subject><subject>Microbial Ecology</subject><subject>Microbiological Techniques</subject><subject>Microbiology</subject><subject>Nystatin - pharmacology</subject><subject>Plant Sciences</subject><subject>Virulence</subject><subject>Virulence (Microbiology)</subject><subject>Virulence Factors - antagonists & inhibitors</subject><subject>Virulence Factors - metabolism</subject><issn>0301-486X</issn><issn>1573-0832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp1ks9u1DAQxiMEokvhAbggS1zgkGI7iZMcVytgI1WqxALiZjn-s7hK7GA7Ffs0fdVOtKWwCOTDyOPfN_aMvyx7SfAFwbh-FwnBJcsxKfO2wTTHj7IVqeoix01BH2crXGCSlw37dpY9i_EaY1CR-ml2RitS0pqyVXa7m_vcuu-2t8mHA9p4J7VLQSTrXUTeoLVL1sxuL4aIdvM0BR0j2urRD4doHVrLZG9sOizoVRAD2ginrBJIDL2VAmrA_iGZgp8gO9iIuugHkXREJvgRbbuveeeMlkkr1AF8Y9UMVz7PnhgI-sV9PM--fHj_ebPNL68-dpv1ZS6rmqVclH2j2qKsGK4NbllREtwqjHXFmr5XRkktelpRXPWKNAL6byBDjWx73QpDivPszbHuFPyPWcfERxulHgbhtJ8jJxVjDW3qkgL6-i_02s_BwesWCtcFKyn7TcHgNLfOeBiqXIryddFU8F3wMUBd_IOCpfRopXfaWMifCN6eCIBJ-mfaizlG3u0-nbLkyMrgYwza8CnYUYQDJ5gvBuJHA3EwEF8MxDFoXt03N_ejVg-KX44BgB6BCEdur8Mf3f-36h1ZxdCj</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Anil, Sukumaran</creator><creator>Hashem, Mohamed</creator><creator>Vellappally, Sajith</creator><creator>Patil, Shankargouda</creator><creator>Bandara, H. M. H. N.</creator><creator>Samaranayake, L. P.</creator><general>Springer Netherlands</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20141001</creationdate><title>Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals</title><author>Anil, Sukumaran ; Hashem, Mohamed ; Vellappally, Sajith ; Patil, Shankargouda ; Bandara, H. M. H. N. ; Samaranayake, L. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Amphotericin B</topic><topic>Amphotericin B - pharmacology</topic><topic>Antifungal agents</topic><topic>Antifungal Agents - pharmacology</topic><topic>Antiparasitic agents</topic><topic>Biocides</topic><topic>Biomedical and Life Sciences</topic><topic>Candida albicans</topic><topic>Candida albicans - drug effects</topic><topic>Candida albicans - isolation & purification</topic><topic>Candida albicans - metabolism</topic><topic>Candida tropicalis</topic><topic>Candida tropicalis - drug effects</topic><topic>Candida tropicalis - isolation & purification</topic><topic>Candida tropicalis - metabolism</topic><topic>Candidiasis, Oral - microbiology</topic><topic>Dentistry</topic><topic>Enzymes</topic><topic>Eukaryotic Microbiology</topic><topic>Fluconazole</topic><topic>Fluconazole - pharmacology</topic><topic>Fungi</topic><topic>Health aspects</topic><topic>Hemolysin Proteins - antagonists & inhibitors</topic><topic>Hemolysin Proteins - secretion</topic><topic>HIV</topic><topic>HIV (Viruses)</topic><topic>HIV infection</topic><topic>HIV Infections - complications</topic><topic>HIV patients</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infections</topic><topic>Life Sciences</topic><topic>Medical Microbiology</topic><topic>Microbial Ecology</topic><topic>Microbiological Techniques</topic><topic>Microbiology</topic><topic>Nystatin - pharmacology</topic><topic>Plant Sciences</topic><topic>Virulence</topic><topic>Virulence (Microbiology)</topic><topic>Virulence Factors - antagonists & inhibitors</topic><topic>Virulence Factors - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anil, Sukumaran</creatorcontrib><creatorcontrib>Hashem, Mohamed</creatorcontrib><creatorcontrib>Vellappally, Sajith</creatorcontrib><creatorcontrib>Patil, Shankargouda</creatorcontrib><creatorcontrib>Bandara, H. M. H. N.</creatorcontrib><creatorcontrib>Samaranayake, L. P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Mycopathologia (1975)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anil, Sukumaran</au><au>Hashem, Mohamed</au><au>Vellappally, Sajith</au><au>Patil, Shankargouda</au><au>Bandara, H. M. H. N.</au><au>Samaranayake, L. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals</atitle><jtitle>Mycopathologia (1975)</jtitle><stitle>Mycopathologia</stitle><addtitle>Mycopathologia</addtitle><date>2014-10-01</date><risdate>2014</risdate><volume>178</volume><issue>3-4</issue><spage>207</spage><epage>215</epage><pages>207-215</pages><issn>0301-486X</issn><eissn>1573-0832</eissn><abstract>Secretion of hydrolytic enzymes such as hemolysin is considered an important virulence attribute of the opportunistic pathogenic fungus
Candida
. It is known that
Candida
spp. isolated from HIV-infected patients produce copious hemolysins. As common antifungal agents may perturb the production of extracellular enzymes, we evaluated the effect of three antifungals nystatin, amphotericin B and fluconazole on the hemolytic activity of
Candida albicans
and
Candida tropicalis
isolates from HIV-infected individuals. The impact of antimycotics on hemolytic activity was assessed by a previously described in vitro plate assay, after exposing ten isolates each of
C. albicans
and
C. tropicalis
recovered from HIV-infected individuals to sub-minimum inhibitory concentrations (sub-MIC) of nystatin, amphotericin B and fluconazole. All
Candida
isolates showed a significant reduction in hemolytic activity. The reduction was highest for amphotericin B-exposed
C. albicans
and
C. tropicalis
followed by nystatin and fluconazole. The effect of antimycotics was more pronounced on the hemolytic activity of
C. tropicalis
compared to that of
C. albicans
. Commonly used antifungal agents significantly suppress hemolysin activity of
Candida
species. This implies that the antifungals, in addition to their lethality, may modulate key virulence attributes of the yeast. The clinical relevance of this phenomenon in HIV disease and other similar pathologies remains to be determined.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>25142726</pmid><doi>10.1007/s11046-014-9802-0</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-486X |
ispartof | Mycopathologia (1975), 2014-10, Vol.178 (3-4), p.207-215 |
issn | 0301-486X 1573-0832 |
language | eng |
recordid | cdi_proquest_miscellaneous_1566828742 |
source | Springer Nature |
subjects | Amphotericin B Amphotericin B - pharmacology Antifungal agents Antifungal Agents - pharmacology Antiparasitic agents Biocides Biomedical and Life Sciences Candida albicans Candida albicans - drug effects Candida albicans - isolation & purification Candida albicans - metabolism Candida tropicalis Candida tropicalis - drug effects Candida tropicalis - isolation & purification Candida tropicalis - metabolism Candidiasis, Oral - microbiology Dentistry Enzymes Eukaryotic Microbiology Fluconazole Fluconazole - pharmacology Fungi Health aspects Hemolysin Proteins - antagonists & inhibitors Hemolysin Proteins - secretion HIV HIV (Viruses) HIV infection HIV Infections - complications HIV patients Human immunodeficiency virus Humans Infections Life Sciences Medical Microbiology Microbial Ecology Microbiological Techniques Microbiology Nystatin - pharmacology Plant Sciences Virulence Virulence (Microbiology) Virulence Factors - antagonists & inhibitors Virulence Factors - metabolism |
title | Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T01%3A11%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sub-inhibitory%20Concentrations%20of%20Antifungals%20Suppress%20Hemolysin%20Activity%20of%20Oral%20Candida%20albicans%20and%20Candida%20tropicalis%20Isolates%20from%20HIV-Infected%20Individuals&rft.jtitle=Mycopathologia%20(1975)&rft.au=Anil,%20Sukumaran&rft.date=2014-10-01&rft.volume=178&rft.issue=3-4&rft.spage=207&rft.epage=215&rft.pages=207-215&rft.issn=0301-486X&rft.eissn=1573-0832&rft_id=info:doi/10.1007/s11046-014-9802-0&rft_dat=%3Cgale_proqu%3EA385802486%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1560736426&rft_id=info:pmid/25142726&rft_galeid=A385802486&rfr_iscdi=true |